⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GKOS News
Glaukos Corporation
Form 8-K
sec.gov
GKOS
Global Capsid Tropism Screening Platforms Market Report 2026 | Capitalize on 14.4% CAGR to $1.45B by 2030 as Sarepta, Voyager, REGENXBIO and Dyno Scale AI and NGS Screening
globenewswire.com
SRPT
RGNX
GKOS
PM360 2026 Trailblazer Awards Winners Announced: Top Companies, Marketers, CEOs, Products, and Initiatives Honored at Gala, Sept. 29th
prnewswire.com
ABT
AZN
CYTK
ARDX
LLY
REGN
NVO
KURA
NOV
BMY
MRK
ARGX
BMRN
TAK
VRTX
GSK
APMD
GKOS
GEN
LAR
ABBV
INCY
GILD
MOD
IQV
PFE
ALGN
SCL
Form 8-K
sec.gov
GKOS
Form 8-K
sec.gov
GKOS
Glaukos Announces Second Quarter 2026 Financial Results
businesswire.com
GKOS
Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others
globenewswire.com
EL
ALC
STAA
GKOS
RELI
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
businesswire.com
GKOS
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
businesswire.com
GKOS
Form 8-K
sec.gov
GKOS